The use of prostatic peptides in the treatment of prostate diseases

Abstract

The article covers the possibilities of clinical use of bioregulatory peptides of the prostate in the treatment of urological diseases. The mechanisms of the therapeutic action of prostatic peptides are described. The author gives his own experience of using the drug Samprost in the treatment of patients with a urological disease. (For citation: G.V. Uchvatkin1,2, M.B.Tatarinceva. The use of prostatic peptides in the treatment of prostate diseases. Urologicheskie vedomosti. 2017;7(3):44-48. doi: 10.17816/uroved7344-48).